Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $10.01 $18.75 Friday, 10th May 2024 ITOS stock ended at $17.44. This is 43.07% more than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 13.09% from a day low at $16.58 to a day high of $18.75.
90 days $9.70 $18.75
52 weeks $8.20 $18.75

Historical Iteos Therapeutics Inc. prices

Date Open High Low Close Volume
May 10, 2024 $16.75 $18.75 $16.58 $17.44 5 229 788
May 09, 2024 $12.22 $12.48 $12.00 $12.19 77 151
May 08, 2024 $12.23 $12.33 $11.94 $12.20 142 849
May 07, 2024 $12.41 $12.54 $12.00 $12.31 205 160
May 06, 2024 $11.85 $12.42 $11.72 $12.41 300 243
May 03, 2024 $11.72 $11.92 $11.51 $11.66 269 230
May 02, 2024 $11.89 $11.89 $11.27 $11.49 285 861
May 01, 2024 $10.81 $11.81 $10.60 $11.78 405 036
Apr 30, 2024 $10.79 $10.88 $10.70 $10.74 144 347
Apr 29, 2024 $10.83 $11.03 $10.72 $10.78 138 721
Apr 26, 2024 $10.59 $10.90 $10.55 $10.80 135 657
Apr 25, 2024 $10.48 $10.62 $10.30 $10.60 163 274
Apr 24, 2024 $11.00 $11.01 $10.56 $10.57 139 379
Apr 23, 2024 $10.80 $11.10 $10.76 $10.99 295 177
Apr 22, 2024 $10.65 $11.15 $10.46 $10.79 174 072
Apr 19, 2024 $10.27 $10.61 $10.01 $10.56 930 784
Apr 18, 2024 $10.62 $10.63 $10.24 $10.33 193 561
Apr 17, 2024 $11.15 $11.22 $10.62 $10.68 191 803
Apr 16, 2024 $11.69 $11.69 $11.06 $11.10 111 670
Apr 15, 2024 $11.78 $11.99 $11.62 $11.76 127 251
Apr 12, 2024 $12.22 $12.37 $11.57 $11.72 126 461
Apr 11, 2024 $12.31 $12.46 $12.15 $12.30 94 375
Apr 10, 2024 $12.32 $12.37 $11.93 $12.24 188 778
Apr 09, 2024 $12.23 $13.35 $12.23 $12.65 186 141
Apr 08, 2024 $12.38 $12.66 $12.18 $12.22 188 776
Click to get the best stock tips daily for free!

About Iteos Therapeutics Inc.

Iteos Therapeutics. Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1/2 clinical trial, as well as used t... ITOS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT